We are live on
!
Find out more
AG
Artal Group Portfolio holdings
AUM
$931M
1-Year Est. Return
41.63%
This Fund
S&P 500
This Quarter
Est. Return
+5.36%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$3.18B
AUM Growth
–
Cap. Flow
+$2.3B
Cap. Flow
% of AUM
72.21%
Top 10 Holdings %
Top 10 Hldgs %
73.11%
Holding
88
New
88
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WW
WW International
WW
|
+$1.25B |
| 2 |
Lexicon Pharmaceuticals
LXRX
|
+$550M |
| 3 |
ACOR
Acorda Therapeutics
ACOR
|
+$51.5M |
| 4 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
+$42.1M |
| 5 |
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
|
+$32.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 42.24% |
| 2 | Miscellaneous | 30.4% |
| 3 | Healthcare | 23.61% |
| 4 | Financials | 1.79% |
| 5 | Technology | 0.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $1.32B | 41.61% |
+28,749,089
| New | +$1.25B |
|
|
2
Lexicon Pharmaceuticals
LXRX
$894M
| $550M | 17.3% |
+36,196,019
| New | +$550M |
|
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$799B
| $96.3M | 3.03% |
+600,000
| New | +$96.6M |
|
4
CALL
iShares MSCI Brazil ETF
EWZ
$8.6B
| $87.7M | 2.76% |
+2,000,000
| New | +$104M |
|
5
CALL
Apple
AAPL
$4.84T
| $55.5M | 1.75% |
+3,920,000
| New | +$60.3M |
|
|
ACOR
6
DELISTED
Acorda Therapeutics
ACOR
| $49.5M | 1.56% |
+12,500
| New | +$51.5M |
|
7
CALL
Qualcomm
QCOM
$201B
| $48.9M | 1.54% |
+800,000
| New | +$51M |
|
|
AUXL
8
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $43.9M | 1.38% |
+2,637,200
| New | +$42.1M |
|
9
CALL
Merck
MRK
$355B
| $37.2M | 1.17% |
+838,400
| New | +$37.4M |
|
10
CALL
GE Aerospace
GE
$319B
| $32.5M | 1.02% |
+292,127
| New | +$32.3M |
|
11
CALL
JPMorgan Chase
JPM
$937B
| $31.7M | 1% |
+600,000
| New | +$30.5M |
|
|
FURX
12
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $31.2M | 0.98% |
+914,442
| New | +$32.1M |
|
13
CALL
Eli Lilly
LLY
$1.01T
| $29.5M | 0.93% |
+600,000
| New | +$32.6M |
|
14
Nektar Therapeutics
NKTR
$2.28B
| $28.9M | 0.91% |
+166,667
| New | +$25.6M |
|
|
IMGN
15
DELISTED
Immunogen Inc
IMGN
| $28.2M | 0.89% |
+1,700,000
| New | +$27.6M |
|
16
CALL
iShares MSCI Japan ETF
EWJ
$23.3B
| $28.1M | 0.88% |
+625,000
| New | +$28.3M |
|
17
CALL
Teva Pharmaceuticals
TEVA
$45.7B
| $27.4M | 0.86% |
+700,000
| New | +$27.3M |
|
|
ONXX
18
CALL
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $26M | 0.82% |
+300,000
| New | +$27.6M |
|
|
ONXX
19
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $26M | 0.82% |
+300,000
| New | +$27.6M |
|
20
CALL
iShares MSCI Mexico ETF
EWW
$1.71B
| $22.8M | 0.72% |
+350,000
| New | +$24.3M |
|
21
CALL
Goldman Sachs
GS
$284B
| $22.7M | 0.71% |
+150,000
| New | +$22.9M |
|
|
22
Apple
AAPL
$4.84T
| $19.8M | 0.62% |
+1,400,000
| New | +$21.5M |
|
23
BioMarin Pharmaceuticals
BMRN
$12.5B
| $19.5M | 0.61% |
+350,000
| New | +$21.8M |
|
24
CALL
Bank of America
BAC
$416B
| $19.3M | 0.61% |
+1,500,000
| New | +$19.1M |
|
25
MetLife
MET
$62.4B
| $18.3M | 0.58% |
+448,800
| New | +$16.5M |
|
Similar funds
BCM
ACM
SAM
NS
PA
ACM
CICI
CAM
Artal Group's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Artal Group, which disclosed 88 positions worth $3.18B. Its ten largest holdings account for 73% of the portfolio.
Its largest position is WW International: 28,749,089 shares worth $1.32B.
By sector, the portfolio is most concentrated in Consumer Discretionary at 42% of assets, followed by Miscellaneous and Healthcare.
- Artal Group's largest Q2 2013 buy was WW International: 28,749,089 shares worth $1.32B.
- Artal Group's ten largest holdings make up 73% of its $3.18B portfolio in Q2 2013.
- Artal Group disclosed 88 positions in Q2 2013, its first 13F filing on record.
Based on Artal Group's 13F filing for Q2 2013, filed 13 Aug 2013.